scorecard

You Searched For "Coronavirus drugs" and got 18 results


Sort By:


Business Insider Latest Story Image
3 mins read

2 leading disease modelers predict low COVID rates this summer — but we may need new vaccines by fall

Infectious disease modelers told the FDA we're "peaking" at around 80% immunity against Omicron now…

Hilary Brueck   


Business Insider Latest Story Image
5 mins read

FDA advisors call for an end to never-ending booster shots as they try to map out a strategy for living with COVID

"We simply can't be boosting people as frequently as we are," the FDA's Peter Marks acknowledged on…

Hilary Brueck   


Business Insider Latest Story Image
9 mins read

The ivermectin battle isn't over: COVID-19 doctors are prescribing the drug in plain sight

Misinformation campaigns and hero complexes drive doctors to dole out ivermectin for COVID-19, desp…

Aria Bendix   


Business Insider Latest Story Image
3 mins read

An aggressive HIV variant silently spread in the Netherlands for 2 decades — a cautionary tale for the current pandemic

European researchers identified 109 people in the Netherlands with an aggressive HIV variant dating…

Aria Bendix   


Business Insider Latest Story Image
2 mins read

Former FDA commissioner says schools should not mandate boosters for children

"I think this should be left up to the discretion of parents and their physicians," Scott Gottlieb …

Yelena Dzhanova   


Business Insider Latest Story Image
1 min read

Grace Dean   


Business Insider Latest Story Image
4 mins read

FDA authorizes boosters of the Pfizer-BioNTech coronavirus vaccine for older adults and others at high risk from COVID-19

The hope is that booster shots will help protect those most at risk as the pandemic continues to ra…

Andrew Dunn   


Business Insider Latest Story Image
2 mins read

Inside the battle that's brewing as psychedelic companies fight for patent rights

These are Insider's biggest healthcare stories for November 9.

Leah Rosenbaum   


Business Insider Latest Story Image
2 mins read

Former FDA commissioner says 'we're close to the end of the pandemic phase' as kids get vaccinated and COVID-19 pills emerge

Gottlieb on Sunday said he expected the Delta variant to continue to spread throughout the country,…

Connor Perrett   


Business Insider Latest Story Image
1 min read

Why so many drug companies are now RNA companies

These are Insider's biggest healthcare stories for October 6.

Leah Rosenbaum   


Business Insider Latest Story Image
5 mins read

Omicron has drug companies preparing for the worst. Here are their plans to counterattack the newest COVID-19 variant.

Experts fear that the newest variant may make vaccines and therapies less effective. "On the face o…

Andrew Dunn   


Business Insider Latest Story Image
4 mins read

How a group with right-wing ties duped tens of thousands of Americans into buying COVID-19 drugs that don't work

Patients may have spent $6.7 million for medical advice and $8.5 million for prescriptions, The Int…

Aria Bendix   


Business Insider Latest Story Image
2 mins read

Lilly paused it coronavirus antibody drug trial

These are Business Insider's biggest healthcare stories for October 14.

Lydia Ramsey Pflanzer   


Business Insider Latest Story Image
4 mins read

CDC advisors raise concerns about 'over-vaccination' and ask the White House for more data to show boosters are needed

A select few may derive real benefits from a third shot, but other Americans may not, said an indep…

Hilary Brueck   


Business Insider Latest Story Image
5 mins read

Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study

Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…

Business Insider Latest Story Image
2 mins read

Unvaccinated Texas GOP gubernatorial candidate Allen West is ill with COVID-19 and medicating with unproven drugs

West said he will most likely have to be hospitalized after his oxygen levels dropped and x-rays sh…

Sarah Al-Arshani   


Business Insider Latest Story Image
3 mins read

FDC launches two variants of COVID-19 drug Favipiravir in India at ₹55 per tablet

FDC has launched two variants of Favipiravir in India at ₹55 per tablet under the brand names PiFLU…

Business Insider Latest Story Image
2 mins read

Biocon to launch drug for COVID-19 patients at ₹ 8,000 per vial

Biotechnology major Biocon on Monday said it will launch biologic drug Itolizumab for the treatme…

PTI